Cargando…

RNA-Based COVID-19 vaccine candidates with clinical phase trials in progress

Due to the COVID-19 infection, which was recognized as a global pandemic by the WHO on March 11, 2020, the number of cases and disease-related deaths increases day by day globally. For this reason, antiviral agents used in treatment and vaccines, the most effective weapon in prevention, continue to...

Descripción completa

Detalles Bibliográficos
Autores principales:	RUDVAN AL, Leyla İpek, SÖNMEZER, Meliha Çağla, ÜNAL, Serhat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771051/ https://www.ncbi.nlm.nih.gov/pubmed/34365779 http://dx.doi.org/10.3906/sag-2104-139

Ejemplares similares

Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey
por: Sonmezer, Meliha Cagla, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey
por: Sonmezer, Meliha Cagla, et al.
Publicado: (2022)

Knowledge and Attitudes of Turkish Physicians towards Human Monkeypox Disease and Related Vaccination: A Cross-Sectional Study
por: Sahin, Taha Koray, et al.
Publicado: (2022)

Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey
por: Sonmezer, Meliha Cagla, et al.
Publicado: (2022)

The Emergence of Echinocandin-Resistant Candida glabrata Exhibiting High MICs and Related FKS Mutations in Turkey
por: Sig, Ali Korhan, et al.
Publicado: (2021)

Evaluation of Risk Factors for Antibiotic Resistance in Patients with Nosocomial Infections Caused by Pseudomonas aeruginosa
por: Sonmezer, Meliha Cagla, et al.
Publicado: (2016)

Seroprevalence of Hepatitis A Virus Antibodies among the Patients with Chronic Hepatitis B in Turkey
por: Tulek, Necla, et al.
Publicado: (2015)

Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species
por: Koksal, Eda, et al.
Publicado: (2019)

A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial
por: Akova, Murat, et al.
Publicado: (2021)

Zika vaccine candidates progress through nonclinical development and enter clinical trials
por: Barrett, Alan D T
Publicado: (2016)

Perspectives on RNA Vaccine Candidates for COVID-19
por: Borah, Pobitra, et al.
Publicado: (2021)

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial
por: Kremsner, Peter G., et al.
Publicado: (2021)

A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates
por: Berry, Donald A., et al.
Publicado: (2020)

The Increase of the Magnitude of Spontaneous Viral Blips in Some Participants of Phase II Clinical Trial of Therapeutic Optimized HIV DNA Vaccine Candidate
por: Akulova, Ekaterina, et al.
Publicado: (2019)

Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials
por: Trillo Aliaga, Pamela, et al.
Publicado: (2021)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: A phase I clinical trial
por: Rowland, Rosalind, et al.
Publicado: (2013)

Assessment of Pulmonary Arterial Hemodynamic and Vascular Changes by Pulmonary Pulse Transit Time in Patients with Human Immunodeficiency Virus Infection
por: Erdol, Mehmet Akif, et al.
Publicado: (2021)

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity
por: Pérez-Rodríguez, Sonia, et al.
Publicado: (2022)

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
por: Walsh, Edward E., et al.
Publicado: (2020)

Vaccine Development against COVID-19: Study from Pre-Clinical Phases to Clinical Trials and Global Use
por: Ahmed, Sagheer, et al.
Publicado: (2021)

The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials
por: Singh, Jerome Amir, et al.
Publicado: (2021)

Coronavirus Anxiety Level and COVID-19 Vaccine Attitude Among Patients With Hematological Malignancies
por: Güven, Zeynep Tuğba, et al.
Publicado: (2023)

AMH standardization and preanalytical phase as two sides of the same coin
por: Demirci, Gülşah, et al.
Publicado: (2023)

Hairy cell leukemia followed by polycythemia vera: report of the first case
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2016)

Current COVID-19 vaccine candidates: Implications in the Saudi population
por: Raja, AlAnoud TofailAhmed, et al.
Publicado: (2020)

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
por: Yönal-Hindilerden, İpek, et al.
Publicado: (2023)

A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children
por: Bélard, Sabine, et al.
Publicado: (2011)

Phase I Randomised Clinical Trial of an HIV-1(CN54), Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally
por: Lewis, David J., et al.
Publicado: (2011)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in Adults with Hematologic Malignancies: A Phase III, Randomized Clinical Trial
por: Oostvogels, Lidia
Publicado: (2017)

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial
por: Turner, Mark, et al.
Publicado: (2020)

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
por: Tumban, Ebenezer
Publicado: (2020)

Ongoing pregnancy and healthy live births following very short ovarian stimulation of incidentally observed big antral follicles in oligoamenorrheic patients with extremely decreased ovarian reserve
por: Turan, Volkan, et al.
Publicado: (2021)

Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A
por: Wajja, Anne, et al.
Publicado: (2018)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
por: Moris, Philippe, et al.
Publicado: (2017)

Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
por: Schmidt, Christin, et al.
Publicado: (2023)

Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
por: Zhou, Fangbin, et al.
Publicado: (2023)

A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants
por: Afolabi, Muhammed O., et al.
Publicado: (2013)

Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175
por: Chitnis, Chetan E., et al.
Publicado: (2015)

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
por: Gaudinski, Martin R, et al.
Publicado: (2018)

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children
por: Langley, Joanne M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8ikq6ktl41avmuh8r2ml9mvmq9